Prima BioMed's therapy improves survival rates in ovarian cancer
May 14, 2014 at 18:02 PM EDT
May 14 (Reuters) - Prima BioMed Ltd said its experimental lead treatment improved survival in some ovarian cancer patients without the disease worsening.